Format

Send to

Choose Destination
See comment in PubMed Commons below
Hepatology. 2010 Mar;51(3):1055-61. doi: 10.1002/hep.23344.

Therapeutic RNA manipulation in liver disease.

Author information

1
Division of Gastroenterology, Box 8124, Washington University School of Medicine, 660 Euclid Avenue, St. Louis, MO 63110, USA. nod@wustl.edu

Abstract

Posttranscriptional regulation of gene expression is increasingly recognized as a model for inherited and acquired disease. Recent work has expanded understanding of the range of mechanisms that regulate several of these distinct steps, including messenger RNA (mRNA) splicing, trafficking, and/or stability. Each of these pathways is implicated in disease pathogenesis, and each represents important avenues for therapeutic intervention. This review summarizes important mechanisms controlling mRNA processing and the regulation of mRNA degradation, including the role of microRNAs and RNA binding proteins. These pathways provide important opportunities for therapeutic targeting directed at splicing and degradation in order to attenuate genetic defects in RNA metabolism. We will highlight developments in vector development and validation for therapeutic manipulation of mRNA expression with a focus on potential applications in metabolic and immunomediated liver disease.

PMID:
19918970
PMCID:
PMC2964871
DOI:
10.1002/hep.23344
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley Icon for PubMed Central
    Loading ...
    Support Center